Warner Chilcott Challenges Watson's Generic Contraceptive

Law360, New York (May 18, 2012, 1:37 PM EDT) -- A Watson Pharmaceuticals Inc. unit was nailed Wednesday with a patent infringement lawsuit in New Jersey federal court over its plan to make a generic version of Warner Chilcott Co. LLC's birth control medication Lo Loestrin Fe.

Puerto Rico-based Warner Chilcott — a unit of Dublin, Ireland's Warner Chilcott PLC — said in the suit that Watson Laboratories' plans to file an abbreviated new drug application for the generic with the U.S. Food and Drug Administration would infringe U.S. Patent Numbers 5,552,394 and 7,704,984, which cover...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.